Last reviewed · How we verify
NCT02453217: CHIP
The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial
NA trial testing Chinese CHIP in Severe Mental Illness in 144 participants. Completed in 31 January 2019.
30 November 2018
Quick facts
| Lead sponsor | Wai-Tong Chien |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 144 |
| Start date | 31 March 2016 |
| Primary completion | 30 November 2018 |
| Estimated completion | 31 January 2019 |
Drugs / interventions tested
- Chinese CHIP
- Treatment as usual
Conditions studied
- Severe Mental Illness — all drugs for Severe Mental Illness →
- Schizophrenia — all drugs for Schizophrenia →
- Schizoaffective Disorder — all drugs for Schizoaffective Disorder →
- Bipolar Affective Disorder — all drugs for Bipolar Affective Disorder →
Sponsor
Wai-Tong Chien
Who can join
Adults 18 to 65, any sex, with Severe Mental Illness or Schizophrenia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators programme of research will evaluate an existing physical health care screening intervention with the aim of helping Community Psychiatric Nurses (CPN) to improve the physical health wellbeing of people with a SMI. This pilot clustered randomised controlled trial aims to establish the potential efficacy and acceptability of the Chinese Health Improvement Profile (CHIP) in improving the physical health of people with severe mental illness.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Cardiometabolic health, prescribed antipsychotics and health-related quality of life in people with schizophrenia-spectrum disorders: a cross-sectional study.
Bressington D, Mui J, Tse ML, Gray R, et al · · 2016 · cited 27× · PMID 27863522 · DOI 10.1186/s12888-016-1121-1
Verify or expand the search:
- PubMed search for NCT02453217
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Severe Mental Illness
Currently open trials in the same condition.
- NCT07470346 — Musical Intervention for the Management of Anxiety and Stress in People With Severe Mental Disorder in a Medium-stay Uni · NA · active not recruiting
- NCT06914622 — Real-time Experiences, Physical Activity and Biological Outcomes in Personal Recovery Residents (EMPOWER-RES) · NA · recruiting
- NCT07360665 — Multimodal Physical Exercise Program (Physical Exercise for Psychosis) for People With Psychosis Treated With Long-Actin · NA · recruiting
- NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
- NCT07085923 — Norwegian Mental Illness Heart Health Study · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02453217 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wai-Tong Chien
- Last refreshed: 22 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02453217.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing